Claire Galambrun

5.9k total citations
79 papers, 2.5k citations indexed

About

Claire Galambrun is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Claire Galambrun has authored 79 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Hematology, 23 papers in Public Health, Environmental and Occupational Health and 15 papers in Genetics. Recurrent topics in Claire Galambrun's work include Hematopoietic Stem Cell Transplantation (32 papers), Acute Lymphoblastic Leukemia research (22 papers) and Acute Myeloid Leukemia Research (12 papers). Claire Galambrun is often cited by papers focused on Hematopoietic Stem Cell Transplantation (32 papers), Acute Lymphoblastic Leukemia research (22 papers) and Acute Myeloid Leukemia Research (12 papers). Claire Galambrun collaborates with scholars based in France, United States and Italy. Claire Galambrun's co-authors include Nathalie Bleyzac, Yves Bertrand, Jean Louis Stéphan, G Souillet, Y. Bertrand, Pierre Bordigoni, Yves Bertrand, Françoise Méchinaud, G. Aulagner and André Baruchel and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PEDIATRICS.

In The Last Decade

Claire Galambrun

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Galambrun France 29 1.3k 583 494 489 483 79 2.5k
Arnaud Petit France 25 969 0.8× 630 1.1× 288 0.6× 293 0.6× 382 0.8× 129 2.3k
Arcangelo Prete Italy 32 1.2k 1.0× 479 0.8× 369 0.7× 476 1.0× 240 0.5× 132 3.0k
Ron Ram Israel 26 1.1k 0.9× 509 0.9× 338 0.7× 217 0.4× 388 0.8× 139 2.3k
Renate Arnold Germany 25 1.4k 1.1× 714 1.2× 696 1.4× 245 0.5× 299 0.6× 77 2.4k
Andreas Hirt Switzerland 26 1.3k 1.1× 321 0.6× 856 1.7× 325 0.7× 430 0.9× 89 3.1k
Morris Kletzel United States 29 974 0.8× 384 0.7× 337 0.7× 559 1.1× 474 1.0× 148 3.1k
Peter Kalhs Austria 34 2.4k 1.9× 472 0.8× 1.1k 2.1× 197 0.4× 478 1.0× 119 3.3k
Paolo de Fabritiis Italy 32 1.8k 1.4× 570 1.0× 381 0.8× 203 0.4× 814 1.7× 199 3.2k
Adrian Goycoolea 2 1.6k 1.3× 381 0.7× 556 1.1× 265 0.5× 424 0.9× 3 2.8k
Isabel Badell Spain 24 806 0.6× 328 0.6× 265 0.5× 264 0.5× 279 0.6× 108 1.6k

Countries citing papers authored by Claire Galambrun

Since Specialization
Citations

This map shows the geographic impact of Claire Galambrun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Galambrun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Galambrun more than expected).

Fields of papers citing papers by Claire Galambrun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Galambrun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Galambrun. The network helps show where Claire Galambrun may publish in the future.

Co-authorship network of co-authors of Claire Galambrun

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Galambrun. A scholar is included among the top collaborators of Claire Galambrun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Galambrun. Claire Galambrun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saultier, Paul, Zeinab Hamidou, Jean‐Claude Gentet, et al.. (2021). A Randomized Trial of Physical Activity in Children and Adolescents with Cancer. Cancers. 13(1). 121–121. 25 indexed citations
2.
Neven, Bénédicte, Jean‐Hugues Dalle, Claire Galambrun, et al.. (2020). Ruxolitinib in children with steroid‐refractory acute graft‐versus‐host disease: A retrospective multicenter study of the pediatric group of SFGM‐TC. Pediatric Blood & Cancer. 67(9). e28233–e28233. 14 indexed citations
3.
Rotulo, Gioacchino Andrea, Blandine Beaupain, Fanny Rialland, et al.. (2020). HSCT may lower leukemia risk in ELANE neutropenia: a before–after study from the French Severe Congenital Neutropenia Registry. Bone Marrow Transplantation. 55(8). 1614–1622. 24 indexed citations
4.
Oger, Emmanuel, Jean‐Hugues Dalle, Yves Bertrand, et al.. (2020). Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?. Pediatric Hematology and Oncology. 37(3). 259–268. 2 indexed citations
5.
Fontbrune, Flore Sicre de, Claire Galambrun, Anne Sîrvent, et al.. (2015). Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy. Transplantation. 99(9). 1953–1959. 102 indexed citations
6.
7.
Paci, Angélo, Gilles Vassal, Despina Moshous, et al.. (2012). Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children. Therapeutic Drug Monitoring. 34(2). 198–208. 65 indexed citations
8.
Motte, Anne, et al.. (2011). Hepatitis E in three immunocompromized children in southeastern France. Journal of Clinical Virology. 53(2). 162–166. 31 indexed citations
9.
Michel, Gérard, Dominique Valteau‐Couanet, Jean‐Claude Gentet, et al.. (2011). Weight‐based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results. Pediatric Blood & Cancer. 58(1). 90–97. 40 indexed citations
10.
Méchinaud, Françoise, Claire Galambrun, Neïla Ben Romdhane, et al.. (2010). Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia. Journal of Medical Genetics. 47(10). 686–691. 90 indexed citations
11.
Rénard, C., Vincent Barlogis, Valérie Mialou, et al.. (2010). Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. British Journal of Haematology. 152(3). 322–330. 55 indexed citations
12.
Kanold, Justyna, Étienne Merlin, Pascale Halle, et al.. (2007). Photopheresis in pediatric graft‐versus‐host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion. 47(12). 2276–2289. 75 indexed citations
13.
Bleyzac, Nathalie, Claire Galambrun, Valérie Mialou, et al.. (2007). Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study. Therapeutic Drug Monitoring. 29(2). 177–184. 33 indexed citations
14.
Galambrun, Claire, et al.. (2007). Risk‐adjusted monitoring of veno‐occlusive disease following Bayesian individualization of busulfan dosage for bone marrow transplantation in paediatrics. Pharmacoepidemiology and Drug Safety. 17(2). 135–143. 9 indexed citations
15.
Maury, Sébastien, Zina Chir, Jean-Michel Boiron, et al.. (2007). Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica. 92(5). 589–596. 80 indexed citations
16.
Berger, Claire, Béatrice Trombert‐Paviot, N. Mitton, et al.. (2006). Les cancers de l'enfant de la région Rhône-Alpes : incidence et survie 1987–1999. Archives de Pédiatrie. 13(2). 121–129. 23 indexed citations
17.
Giliani, Silvia, Luigi Mori, Geneviève de Saint Basile, et al.. (2005). Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients. Immunological Reviews. 203(1). 110–126. 118 indexed citations
18.
Berger, Claire, Jean Donadieu, O. Richard, et al.. (2005). Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia. Bone Marrow Transplantation. 35(10). 991–995. 54 indexed citations
19.
Bleyzac, Nathalie, G Souillet, Paul J. Martin, et al.. (2001). Improved clinical outcome of paediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens. Bone Marrow Transplantation. 28(8). 743–751. 113 indexed citations
20.
Gautheron, V., et al.. (1995). Anticorps anticardiolipine, ischémie cérébrale et hémorragie surrénalienne chez un nouveau-né. Archives de Pédiatrie. 2(11). 1086–1088. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arnaud Petit Breakdown of academic impact, for papers by Arcangelo Prete Breakdown of academic impact, for papers by Ron Ram Breakdown of academic impact, for papers by Renate Arnold Breakdown of academic impact, for papers by Andreas Hirt Breakdown of academic impact, for papers by Morris Kletzel Breakdown of academic impact, for papers by Peter Kalhs Breakdown of academic impact, for papers by Paolo de Fabritiis Breakdown of academic impact, for papers by Adrian Goycoolea Breakdown of academic impact, for papers by Isabel Badell
Rankless by CCL
2026